Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06443814
Other study ID # 1P50AT000082-03
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date July 2001
Est. completion date November 2004

Study information

Verified date May 2024
Source Maharishi International University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized controlled trial compared the efficacy of stress reduction with meditation to a health education (HE) group in 201 older African American women over a one-year study period. They were randomly allocated to either of two behavioral treatment groups-1) the Transcendental Meditation (TM( program or 2) a health education (HE) program. Women participants were recruited, tested, and instructed at two clinical sites: Washington, DC and Atlanta, GA. Outcome measures were carotid intima medial thickness, lipid profile, glucose and insulin resistance, and behavioral factors.


Description:

This was a randomized controlled trial that compared the effects of stress reduction using the Transcendental Meditation technique (TM) to a health education (HE) group in 201 African American women >55 years with high CVD risk over a one-year intervention and follow-up period. All participants were randomly allocated to either of two behavioral treatment groups-1) the Transcendental Meditation (TM) program or 2) a health education (HE) program of healthy diet, exercise and substance use control. Women participants were recruited, tested, and instructed at two sites:139 were recruited and randomized in Washington, DC and 61 in Atlanta, GA. Outcome measures were carotid intima medial thickness (IMT), lipid profile, glucose and insulin response, blood pressure and lifestyle (diet, exercise, substance use).


Recruitment information / eligibility

Status Completed
Enrollment 201
Est. completion date November 2004
Est. primary completion date November 2004
Accepts healthy volunteers No
Gender Female
Age group 55 Years and older
Eligibility Inclusion Criteria: - African American women, - age 55 or older with at least one of the five cardiovascular conditions (below): - coronary heart disease or - positive coronary angiography or - previous MI or - coronary revascularization or - percutaneous transluminal coronary angioplasty (PTCA). These conditions were medically documented for the study eligibility and subsequent randomization. In the absence of these CAD markers: a high risk factor assessment score of at least two points based on the Framingham study/ATP III report was also accepted for eligibility. Risk factors included diabetes, high systolic or diastolic BP, high cholesterol, high LDL-low HDL or smoking. Exclusion Criteria: - Myocardial infarction - unstable angina - coronary artery by-pass grafting (CABG) - percutaneous transluminal coronary angioplasty (PTCA) - stroke within the preceding three months - carotid artery endarterectomy - atrial fibrillation - second or third degree AV block - heart failure - clinically significant valvular heart disease - major psychiatric disorders, - current alcohol/dependency disorder - other drug abuse dependency disorder - non-cardiac life-threatening illness - participating in a formal stress management program - plans to move out of the study area or travel extensively - unwillingness to accept randomization into any study group.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Health Education
This is a didactic classroom-based control which educates the patient on adapting a healthier lifestyle through proper diet, exercise, and moderating substance usage according to current AHA guidelines. This intervention does not include a stress management component.
Transcendental Meditation
TM is a natural, effortless mental technique practiced for 20 minutes twice a day (morning and evening) which settles down the mind and body. TM can only be taught through a certified instructor and a 7-step process taking place over 4 consecutive days after which the meditator can practice correctly at home twice a day.

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Robert Schneider, MD Howard University, Morehouse School of Medicine

Outcome

Type Measure Description Time frame Safety issue
Primary carotid intima medial thickness B mode ultrasound measure of carotid artery wall thickness 0 and 12 months
Secondary insulin resistance and glucose using the HOMA index 0 and 12 months
Secondary lipid profile LDL, HDL, total cholesterol (TC), triglycerides (TG) (for LDL, TC and TG), a higher score indicates a worst outcome, for HDL a higher score indicates a better outcome 0 and 12 months
Secondary blood pressure measured three times with a mercury sphygmomanometer 5 minutes apart and last two reading averaged 0, 4 and 12 months
Secondary general perceived health SF-36 (numerical likert scale and YES/NO response categories are variable in terms of indicating a better or worse outcome) 0, 4 and 12 months
Secondary Dietary habits block diet questionaire (food choice with pictures) not scaled to indicate a better or worse outcome) 0, 4 and 12 months
Secondary Physical Activity Exercise --using the Folsom Physical Activity Questionaire--not scaled to indicate a better or worse outcome 0, 4 and 12 months
Secondary Substance use substance usage questionnaire for alcohol and illicit drug usage 0, 4 and 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT04635202 - Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome N/A
Completed NCT05343858 - Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome N/A
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Recruiting NCT05040958 - Carotid Atherosclerotic Plaque Load and Neck Circumference
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Active, not recruiting NCT02500147 - Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Phase 4
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Completed NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan N/A
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT06057896 - Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
Active, not recruiting NCT03613740 - Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Phase 2
Completed NCT04498455 - Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency Phase 4
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT03697382 - Effect of Daily Steps on Fat Metabolism N/A
Completed NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Completed NCT04509206 - Virtual Teaching Kitchen N/A
Completed NCT05124847 - TREating Pediatric Obesity N/A